Petra Thulin
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
-
- MicroRNA in disease regulation
Papers in
-
- Peroxisome Proliferator-Activated Receptors 6
- Metabolism, Diabetes, and Cancer 1
-
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Ewa Ehrenborg (6 shared papers)Björn Glinghammar (7 shared papers)L.K. Cheung (1 shared paper)Rachel M. Fisher (1 shared paper)Tianling Wei (1 shared paper)Martin Corcoran (1 shared paper)Dan Grandér (1 shared paper)Daniel J. Antoine (2 shared papers)
- Journals
- International Journal of Molecular Medicine (3 papers)Biochemical and Biophysical Research Communications (1 paper)Toxicology and Applied Pharmacology (1 paper)BMC Molecular Biology (1 paper)Journal of Lipid Research (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Petra Thulin
11 papers receiving 320 citations
Peers
Comparison fields: 5 of 52
- Pharmacology 100
- Cancer Research 82
- Hepatology 41
- Epidemiology 78
- Endocrinology, Diabetes and Metabolism 32
Countries citing papers authored by Petra Thulin
This map shows the geographic impact of Petra Thulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Thulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Thulin more than expected).
Fields of papers citing papers by Petra Thulin
This network shows the impact of papers produced by Petra Thulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Thulin. The network helps show where Petra Thulin may publish in the future.
Co-authors
The 25 scholars most cited alongside Petra Thulin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 89 | |
| 2 | 2013 | 74 | |
| 3 | 2008 | 51 | |
| 4 | 2012 | 33 | |
| 5 | 2016 | 26 | |
| 6 | 2007 | 19 | |
| 7 | 2009 | 19 | |
| 8 | 2008 | 11 | |
| 9 | 2016 | 3 | |
| 10 | 2020 | 1 | |
| 11 | 2012 | 1 |
About Petra Thulin
Petra Thulin is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Epidemiology and Clinical Biochemistry, having authored 11 papers that have together received 327 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Metabolism and Genetic Disorders (2 papers), Liver Disease Diagnosis and Treatment (2 papers), NF-κB Signaling Pathways (1 paper), Cancer, Lipids, and Metabolism (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Lipoproteins and Cardiovascular Health (1 paper). The work is most often cited by research in Pharmacology (100 citations), Cancer Research (82 citations), Hepatology (41 citations), Epidemiology (78 citations) and Endocrinology, Diabetes and Metabolism (32 citations). Petra Thulin has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Ewa Ehrenborg, Björn Glinghammar, L.K. Cheung, Rachel M. Fisher, Tianling Wei, Martin Corcoran, Dan Grandér, Daniel J. Antoine, Ina Schuppe‐Koistinen and Gunnar Nordahl. Their work appears in journals such as International Journal of Molecular Medicine, Biochemical and Biophysical Research Communications, Toxicology and Applied Pharmacology, BMC Molecular Biology and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.